AU2001296445A1 - Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents - Google Patents
Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agentsInfo
- Publication number
- AU2001296445A1 AU2001296445A1 AU2001296445A AU9644501A AU2001296445A1 AU 2001296445 A1 AU2001296445 A1 AU 2001296445A1 AU 2001296445 A AU2001296445 A AU 2001296445A AU 9644501 A AU9644501 A AU 9644501A AU 2001296445 A1 AU2001296445 A1 AU 2001296445A1
- Authority
- AU
- Australia
- Prior art keywords
- disease
- therapeutic agents
- regions associated
- predicting responsiveness
- identifying genetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
- 230000004043 responsiveness Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- General Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Data Mining & Analysis (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Ecology (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USNOTGIVEN | 2000-05-23 | ||
| US23676500P | 2000-09-29 | 2000-09-29 | |
| US60/236,765 | 2000-09-29 | ||
| US09/966,870 US20020098498A1 (en) | 2000-09-29 | 2001-09-28 | Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents |
| PCT/US2001/030672 WO2002027034A2 (fr) | 2000-09-29 | 2001-10-01 | Procede d'identification de regions genetiques associees a une maladie et prevision de la reponse a des agents therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001296445A1 true AU2001296445A1 (en) | 2002-04-08 |
Family
ID=26930090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001296445A Abandoned AU2001296445A1 (en) | 2000-09-29 | 2001-10-01 | Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20020098498A1 (fr) |
| AU (1) | AU2001296445A1 (fr) |
| WO (1) | WO2002027034A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU785425B2 (en) | 2001-03-30 | 2007-05-17 | Genetic Technologies Limited | Methods of genomic analysis |
| US8688385B2 (en) | 2003-02-20 | 2014-04-01 | Mayo Foundation For Medical Education And Research | Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype |
| US7335474B2 (en) | 2003-09-12 | 2008-02-26 | Perlegen Sciences, Inc. | Methods and systems for identifying predisposition to the placebo effect |
| US7127355B2 (en) | 2004-03-05 | 2006-10-24 | Perlegen Sciences, Inc. | Methods for genetic analysis |
| CA2911569C (fr) * | 2005-11-29 | 2019-11-26 | Children's Hospital Medical Center | Optimisation et personnalisation de selection et de dosage de medicaments |
| WO2008079374A2 (fr) * | 2006-12-21 | 2008-07-03 | Wang Eric T | Procédés et compositions pour sélectionner et utiliser des polymorphismes d'un nucléotide simple |
| US8315957B2 (en) * | 2009-09-01 | 2012-11-20 | Microsoft Corporation | Predicting phenotypes using a probabilistic predictor |
| CN111199773B (zh) * | 2020-01-20 | 2023-03-28 | 中国农业科学院北京畜牧兽医研究所 | 一种精细定位性状关联基因组纯合片段的评估方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1064398B1 (fr) * | 1998-02-26 | 2010-10-06 | McGinnis, Ralph Evan | Techniques d'etude de liaisons bidimensionnelles |
| US6586183B2 (en) * | 2000-04-13 | 2003-07-01 | Genaissance Pharmaceuticals, Inc. | Association of β2-adrenergic receptor haplotypes with drug response |
-
2001
- 2001-09-28 US US09/966,870 patent/US20020098498A1/en not_active Abandoned
- 2001-10-01 WO PCT/US2001/030672 patent/WO2002027034A2/fr not_active Ceased
- 2001-10-01 AU AU2001296445A patent/AU2001296445A1/en not_active Abandoned
-
2005
- 2005-02-04 US US11/051,167 patent/US20050227267A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020098498A1 (en) | 2002-07-25 |
| WO2002027034A3 (fr) | 2003-08-14 |
| US20050227267A1 (en) | 2005-10-13 |
| WO2002027034A2 (fr) | 2002-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157364A0 (en) | Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1 | |
| AU1047901A (en) | Methods of genetic cluster analysis and use thereof | |
| IL140390A0 (en) | Methods of monitoring disease states and therapies using gene expression profiles | |
| IL153824A0 (en) | Method and kit for diagnosis of diseases | |
| AU2001296511A1 (en) | Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents | |
| AU3494599A (en) | Epitope-driven human antibody production and gene expression profiling | |
| AU2001234608A1 (en) | Methods for analysis of gene expression | |
| IL135261A (en) | Footwear and its method of construction | |
| GB0026424D0 (en) | Genetic analysis of microorganisms | |
| IL138851A0 (en) | Quantitative analysis of gene expression | |
| AU2001296445A1 (en) | Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents | |
| GB9815799D0 (en) | Quantitative analysis of gene expression | |
| IS5742A (is) | Aðferð til genalækninga | |
| AU6387000A (en) | Serial analysis of genetic alterations | |
| AU2001289104A1 (en) | Methods of producing cells and animals comprising targeted gene modifications | |
| AU2002301109A1 (en) | Method for the prediction of preeclampsia and other diseases | |
| GB0015119D0 (en) | Methods and means for regulation of gene expression | |
| AU2002221013A1 (en) | Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease | |
| AU7180701A (en) | Method of managing and marketing livestock based on genetic profiles | |
| AU2001292468A1 (en) | Methods and means of rna analysis | |
| AU2584699A (en) | Immediate early genes and methods of use therefor | |
| AU2002364153A1 (en) | Genetic analysis of gene expression in heterosis | |
| AU2002249453A1 (en) | Enzyme and snp marker for disease | |
| AU2002210761A1 (en) | Method of determining susceptibility to diseases | |
| AU2003228597A8 (en) | Antibodies for enzymes of the omega-oxidation pathway and methods relating thereto |